IXIARO®
ApprovedCompleted 0 watching 0 views this week🔥 Hot
80
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Japanese Encephalitis
Conditions
Japanese Encephalitis
Trial Timeline
Jun 1, 2010 → Oct 1, 2011
NCT ID
NCT01158599About IXIARO®
IXIARO® is a approved stage product being developed by Valneva SE for Japanese Encephalitis. The current trial status is completed. This product is registered under clinical trial identifier NCT01158599. Target conditions include Japanese Encephalitis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
5
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01158599 | Approved | Completed |
Competing Products
20 competing products in Japanese Encephalitis